Janet Briel

Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia

Judith E. Karp, B. Douglas Smith, Mark J. Levis et al. · Clinical Cancer Research · 2007 · 88 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +13

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias

Judith E. Karp, Rebecca M. Ricklis, Kumudha Balakrishnan et al. · Blood · 2007 · 83 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias

Judith E. Karp, Benjamin D. Smith, Linda Resar et al. · Blood · 2011 · 80 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<scp>d</scp>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Judith E. Karp, Antonino Passaniti, Ivana Gojo et al. · Clinical Cancer Research · 2005 · 78 citations

Medicine, Oncology, Pharmacology +16

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells

Christopher G. Kanakry, Allan D. Hess, Christopher D. Gocke et al. · Blood · 2010 · 71 citations · Full text

Life Sciences, Hematology, Immunology +17